Fifteen Isodon diterpenoids (1-15) were evaluated for their cytotoxic activity against HeLa and HL-60 human cancer cell lines, and against murine vincristine (VCR)-resistant P388 cells. Kamebanin (14) showed efficient cytotoxic activity against HeLa and HL-60 cells. In addition, although dihydroenmein (2) and trichorabdal B (7) were inactive against several tested cell types, they were found to have cytotoxic-enhancing activity of VCR against VCR-resistant P388 cells.
Some Isodon species (or Rabdosia; Lamiaceae), which grow in Southeast Asia, are used as herbal medicines [1, 2] . To date, many diterpenes have been isolated from this genus and found to possess the ent-kaurane-type skeleton. Some of these compounds have been reported to exhibit antibacterial and antitumor activities [3] [4] [5] [6] . In our search for natural cytotoxic products, we evaluated 15 diterpenes (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) (15) , encompassing three kaurane types, isolated from various Isodon species, including common ent-kaurane-type diterpenoids, such as inflexin (12), and two additional diterpene types: enmein (1) type, and isodonal (5) type, with spirolactone. Their activities were evaluated using human cervical cancer HeLa and promyelocytic leukemia HL-60 cells. We also performed an evaluation using NIH 3T3 cells. Moreover, 1-15 were evaluated against murine vincristine (VCR)-sensitive P388 cells (P388/S), VCR-resistant P388 cells (P388/VCR[-]), and VCR-resistant P388 cells in the presence of a fairly ineffective amount of VCR (VCR/P388[+]). This study presents the first cytotoxic evaluation report of VCR-resistant P388 cells.
The Isodon diterpenoids 1-15 were evaluated for their cytotoxicity against HeLa and HL-60 cells. The structures of the tested compounds are shown in Figure 1 . Among the 15 tested compounds, the ent-kaurane-type compounds, that is, lasiodin (9), inflexin (12), and kamebanin (14), showed potent activities against both cell lines (IC 50 < 5.0 M). The remaining compounds, isocarpin (3), nodsin (4), effusin (6), oridonin (8), isodomedin (13), and kamebakaunin (15), showed lower but significant cytotoxicity (IC 50 = 4.0-11.1 M). Enmein (1), dihydroenmein (2), isodonal (5), trichorabdal B (7) , shikokiaside A (10), and shikokiaside B (11) were either weakly active or inactive (IC 50 > 20 M) against both cell types. From the viewpoint of the structure-activity relationships of the tested compounds, in the enmein-type compounds (1) (2) (3) (4) , although the exo-methylene group ( 16,17 ) appears to be necessary for this activity, the presence of the hydroxy group at C-3 might decrease the activity. In contact, for the spirolactonetype compounds (5) (6) (7) , the presence of the hydroxy groups as hydrophilic moieties might weaken the activity against both cell types. Furthermore, for ent-kaurane-type compounds (8) (9) (10) (11) (12) (13) (14) (15) , the lack of a carbonyl group at C-15 obviously decreased the activity. Among the 15 tested compounds, compound 14 had the most potent activity against HeLa and HL-60 cells (IC 50 4.1 and 1.3 M, respectively; Table 1 ).
Subsequently, all the compounds were evaluated for their toxicity against NIH 3T3 cells, which represented normal cells. Compound 14 had an efficient NIH 3T3/HL-60 value of 7.2 against the HL-60 cells.
The cytotoxic activities of compounds 1-15 against VCR-sensitive P388 (P388/S) and VCR-resistant P388 cells are summarized in Table 1 . Compounds 3, 4, 8, 9 , 12, and 14 showed potent cytotoxic activities against P388/S, P388/VCR(-), and P388/VCR(+) cells, with IC 50 <2.0 M. For 3, 9, and 14, the cytotoxic data for the resistant cells, P388/VCR(-) and P388/VCR(+), showed enhancingeffects in comparison with the P388/S data.
Furthermore, there was a notable difference in that, although compounds 2, 7, and 11 were inactive against P388/S and P388/VCR(-) cells (IC 50 >120 M), their cytotoxicities against P388/VCR(+) (co-existence of VCR, 15 nM) were clearly enhanced, with IC 50 values = 67, 32, and 63 M, respectively. The VCR-enhancing effect of compound 7 along with VCR was particularly remarkable. Studies on the mechanistic aspect of these phenomena are in progress.
With respect to the cytotoxic activities of the compounds toward VCR-resistant P388 cells, compounds 2, 7 and 11 showed efficient enhancing activities when administered with an ineffective amount of VCR. These results might be significant for overcoming the multi-drug resistance problems that are often encountered in clinical therapies. Furthermore, the results for compound 14, with its IC 50 and NIH 3T3/HL-60 values indicating high cytotoxic activity (Table 1) , are interesting in view of further searches for new entkaurane-type diterpenoids from either Isodon species or other entkaurane plant resources. Although ent-kaurane-type diterpenoids were the major type of diterpenoid found in Isodon species, the seco-type kaurane diterpenoids, enmein, and spirolactone types also showed efficient activity against the tested cancer cell lines. These findings are motivating future work regarding new frameworks from Isodon species.
